Hand Reaction Speed and Manual Dexterity & Caffeine Dependence
NCT ID: NCT07032454
Last Updated: 2025-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
47 participants
OBSERVATIONAL
2025-06-26
2026-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hand Strength And Hand-Reaction Parameters Of Post Millennial: An Example Of Students' Group In Central Anatolia
NCT04249765
Terminal Latency Index, Residual Latency and Median Ulnar F Latency Difference in Carpal Tunnel Syndrome
NCT03499158
Median Nerve Strain and Applied Pressure Measurement in the Carpal Tunnel Syndrome Patients
NCT04027998
Investigation of the Relationship Between Ultrasonographic Parameters and Tactile Sensation in Carpal Tunnel Syndrome
NCT07170449
Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome
NCT07114913
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Caffeine Group (≥300 mg/day)
Individuals consuming 300 mg or more of caffeine daily, meeting DSM-5/ICD-10 criteria for caffeine dependence.
High Caffeine Consumption
Individuals consuming 300 mg or more of caffeine daily, meeting DSM-5/ICD-10 criteria for caffeine dependence.
Low Caffeine Group (≤200 mg/day)
Individuals consuming caffeine within recommended levels (20-200 mg/day).
Low Caffeine Consumption
Individuals consuming caffeine within recommended levels (20-200 mg/day).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Caffeine Consumption
Individuals consuming 300 mg or more of caffeine daily, meeting DSM-5/ICD-10 criteria for caffeine dependence.
Low Caffeine Consumption
Individuals consuming caffeine within recommended levels (20-200 mg/day).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently enrolled university students
Exclusion Criteria
* History of wrist surgery or visible hand deformity
18 Years
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ESRA PEHLIVAN
Assoc.Prof.Dr., PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saglik Bilimleri Universitesi
Istanbul, Üsküdar, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Caffeine_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.